News & Updates

Sitra + nivo slightly better than docetaxel in advanced NSCLC

05 Feb 2024

Treatment with sitravatinib plus nivolumab (sitra + nivo) results in numerically longer median overall survival (OS), albeit statistically nonsignificant, in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC) compared with docetaxel, a study has shown.

Sitra + nivo slightly better than docetaxel in advanced NSCLC

05 Feb 2024

Comorbid sleep-disordered breathing and AF poststroke linked to elevated mortality, recurrence

04 Feb 2024

Stroke patients with comorbid moderate-to-severe sleep-disordered breathing (SDB) and atrial fibrillation (AF) are at heightened risk of long-term mortality or recurrent cerebro-cardiovascular events, according to a study.

Comorbid sleep-disordered breathing and AF poststroke linked to elevated mortality, recurrence

04 Feb 2024

AHA to cardiothoracic surgeons: Get more involved in PE care

04 Feb 2024 by

A scientific statement endorsed by the American Heart Association (AHA) has urged cardiothoracic surgeons to get more involved in the care of patients at high risk for pulmonary embolism (PE) – and to do it much earlier – to improve outcomes.

AHA to cardiothoracic surgeons: Get more involved in PE care

04 Feb 2024

Amivantamab plus chemo improves survival in advanced NSCLC

03 Feb 2024 by

Amivantamab plus chemotherapy with or without lazertinib results in longer progression-free survival (PFS), as well as intracranial PFS, compared with chemotherapy alone in patients with epidermal growth factor receptor (EGFR)-mutated advanced nonsmall-cell lung cancer (NSCLC) who had disease progression on or after osimertinib, results of the phase III MARIPOSA-2 study have shown.

Amivantamab plus chemo improves survival in advanced NSCLC

03 Feb 2024

Cardiac surgery outcomes worsen during COVID

03 Feb 2024 by

Heart surgery during the COVID-19 pandemic took a turn for the worse, with higher cost and poorer survival regardless of people’s socioeconomic status, according to US data.

Cardiac surgery outcomes worsen during COVID

03 Feb 2024

Overweight, obesity fuel risk of developing cardiopulmonary multimorbidity

31 Jan 2024

Being fat contributes to the development of cardiopulmonary (CP) multimorbidity (MM), reports a study. As a result, adiposity may be targeted by future interventions to help prevent MM.

Overweight, obesity fuel risk of developing cardiopulmonary multimorbidity

31 Jan 2024

One-time ceftriaxone cuts ventilator-associated pneumonia risk

28 Jan 2024

A single dose of ceftriaxone appears to reduce the risk of developing early ventilator-associated pneumonia (VAP) in patients with acute brain injury, according to the PROPHY-VAP study.

One-time ceftriaxone cuts ventilator-associated pneumonia risk

28 Jan 2024

Exhalation delivery system with fluticasone passes muster in two chronic rhinosinusitis trials

27 Jan 2024 by

In the treatment of chronic rhinosinusitis (CRS), exhalation delivery system with fluticasone (EDS-FLU) provides relief from symptoms while reducing intrasinus disease and the incidence of acute exacerbations, regardless of the presence of polyps, as shown in the phase III trials ReOpen1 and ReOpen2.

Exhalation delivery system with fluticasone passes muster in two chronic rhinosinusitis trials

27 Jan 2024

Low-dose morphine relieves cough in idiopathic pulmonary fibrosis

24 Jan 2024

In patients with idiopathic pulmonary fibrosis-related cough, treatment with low-dose controlled-release morphine leads to reduced daytime cough frequency and better quality of life, according to data from the phase II PACIFY COUGH crossover trial.

Low-dose morphine relieves cough in idiopathic pulmonary fibrosis

24 Jan 2024

Vaccinated children less likely to experience lingering COVID-19 symptoms

24 Jan 2024 by

SARS-CoV-2 vaccination appears to confer protection against long COVID in the paediatric population, with the protective benefit being stronger in teens.

Vaccinated children less likely to experience lingering COVID-19 symptoms

24 Jan 2024

News & Updates

Filter by Specialty:

Specialty:

Sitra + nivo slightly better than docetaxel in advanced NSCLC

Sitra + nivo slightly better than docetaxel in advanced NSCLC

Comorbid sleep-disordered breathing and AF poststroke linked to elevated mortality, recurrence

Comorbid sleep-disordered breathing and AF poststroke linked to elevated mortality, recurrence

AHA to cardiothoracic surgeons: Get more involved in PE care

AHA to cardiothoracic surgeons: Get more involved in PE care

Amivantamab plus chemo improves survival in advanced NSCLC

Amivantamab plus chemo improves survival in advanced NSCLC

Cardiac surgery outcomes worsen during COVID

Cardiac surgery outcomes worsen during COVID

Overweight, obesity fuel risk of developing cardiopulmonary multimorbidity

Overweight, obesity fuel risk of developing cardiopulmonary multimorbidity

One-time ceftriaxone cuts ventilator-associated pneumonia risk

One-time ceftriaxone cuts ventilator-associated pneumonia risk

Exhalation delivery system with fluticasone passes muster in two chronic rhinosinusitis trials

Exhalation delivery system with fluticasone passes muster in two chronic rhinosinusitis trials

Low-dose morphine relieves cough in idiopathic pulmonary fibrosis

Low-dose morphine relieves cough in idiopathic pulmonary fibrosis

Vaccinated children less likely to experience lingering COVID-19 symptoms

Vaccinated children less likely to experience lingering COVID-19 symptoms